ONCAlert | Upfront Therapy for mRCC
Lymphomas: Articles
Four-Year Follow-Up Data Confirm Durable Responses With CAR T-Cell Therapy in B-Cell Lymphomas
9:13 PM, Tue August 6, 2019
A Look Back at FDA News from July 2019
1:00 PM, Thu August 1, 2019
Frontline Therapy for Mantle Cell Lymphoma Should Be Individualized Expert Urges
7:00 PM, Wed July 24, 2019
Rituximab Biosimilar Approved by FDA for CD20+ B-Cell NHL and CLL
7:22 PM, Tue July 23, 2019
Zanubrutinib Confirmed Highly Active for Relapsed/Refractory MCL
3:00 PM, Tue July 16, 2019
FDA Grants Fast Track Designation to CLR 131 in DLBCL
8:00 PM, Tue July 9, 2019
FDA Approval Sought for sBLAs for New Pembrolizumab Dosing Schedule
5:00 PM, Tue July 9, 2019
A Look Back at FDA News from June 2019
1:04 PM, Mon July 1, 2019
